Verification of vital sign calculation method from FBG sensor signal measured at pulsation point
Phase 1
Not yet recruiting
- Conditions
- Hypertension and diabetes mellitus
- Registration Number
- JPRN-UMIN000042274
- Lead Sponsor
- Shinshu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects having chronic atrial fibrillation, severe arrhythmia, peripheral circulatory failure such as Raynaud's disease, severe deformed nail, and are judged as inappropriate by chief researcher.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie FBG sensor-based arterial strain measurements for blood pressure and glucose estimation in hypertension and diabetes mellitus patients?
How does FBG sensor technology compare to standard-of-care methods in accuracy for blood pressure and glucose monitoring in individuals with hypertension and diabetes mellitus?
Are there specific biomarkers that correlate with improved arterial strain measurement outcomes using FBG sensors in patients with hypertension and diabetes mellitus?
What adverse events are associated with FBG sensor use for continuous vital sign monitoring in patients with hypertension and diabetes mellitus?
What alternative or complementary technologies exist for non-invasive blood pressure and glucose monitoring in hypertension and diabetes mellitus management?